SCHEMBL4600033

SCHEMBL4600033

Cc1ccc(S(=O)(=O)Oc2ccc([C@@H]3CN([C@@H](C)c4ccccc4I)CCO3)cc2)cc1

nearest known ligand 0.39

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.38
CYP3A4 P08684 1/20 0.38
CYP2D6 P10635 1/20 0.38
CYP2C9 P11712 1/20 0.38
CYP2C19 P33261 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
LMNA P02545 2/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
DRD2 P14416 1/20 0.35
DRD1 P21728 1/20 0.35
DRD4 P21917 1/20 0.35
DRD5 P21918 1/20 0.35
DRD3 P35462 1/20 0.35
MAPT P10636 1/20 0.34
ENPP3 O14638 2/20 0.34
ENPP1 P22413 2/20 0.34
ENPP2 Q13822 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2294612 0.87 ALDH1A1 (0.40) ALDH1A1CYP3A4CYP2D6CYP2C9CYP2C19
SCHEMBL2294288 0.87 ALDH1A1 (0.40) ALDH1A1CYP3A4CYP2D6CYP2C9CYP2C19
SCHEMBL2298478 0.87 ALDH1A1 (0.40) ALDH1A1CYP3A4CYP2D6CYP2C9CYP2C19
SCHEMBL2296904 0.87 ALDH1A1 (0.40) ALDH1A1CYP3A4CYP2D6CYP2C9CYP2C19
SCHEMBL2294004 0.81 MOGAT2 (0.40) ALDH1A1CYP2D6DRD3
SCHEMBL2296987 0.81 MOGAT2 (0.40) ALDH1A1CYP2D6DRD3
SCHEMBL4164179 0.81 MOGAT2 (0.40) ALDH1A1CYP2D6DRD3
SCHEMBL2296254 0.81 MOGAT2 (0.40) ALDH1A1CYP2D6DRD3
SCHEMBL2294378 0.81 MOGAT2 (0.40) ALDH1A1CYP2D6DRD3
SCHEMBL2298207 0.77 CYP2D6 (0.47) ALDH1A1CYP3A4CYP2D6CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1910320-A2 INTERMEDIATE COMPOUND FOR SYNTHESIZING PHARMACEUTICAL AGENT AND PRODUCTION METHOD THEREOF Mitsubishi Tanabe Pharma Corporation (JP) 2008-04-16 EP disclosed
WO-2007011065-A2 INTERMEDIATE COMPOUND FOR SYNTHESIZING PHARMACEUTICAL AGENT AND PRODUCTION METHOD THEREOF MITSUBISHI TANABE PHARMA CORPORATION (JP) 2007-01-25 WO disclosed